Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Boyd

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's diseaseHubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Journal of Parkinson'S Disease|December 3, 2016
Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1Robert A Hauser, Ruosha Li, Adriana Pérez, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's DiseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's diseaseHubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Journal of Parkinson'S Disease|December 3, 2016
Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1Robert A Hauser, Ruosha Li, Adriana Pérez, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's DiseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 3